A new medicine for Parkinson’s disease has been approved and launched in the United States. It works in a different way from existing treatments and is expected to cause fewer side effects, according to Belgian neurologist Patrick Santens, who described this as an important advantage. Its availability in Belgian pharmacies has not been specified.